Raymond James Financial
CLBT icon

Raymond James Financial’s Cellebrite CLBT Stock Holding History

Raymond James Financial’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.4M Buy
1,600,460
+210,571
+15% +$2.78M 0.01% 1446
2026
Q1 		$18.4M Sell
1,389,889
-63,207
-4% -$953K 0.01% 1535
2025
Q4 		$26.1M Sell
1,453,096
-42,789
-3% -$768K 0.01% 1257
2025
Q3 		$27.7M Buy
1,495,885
+80,539
+6% +$1.27M 0.01% 1190
2025
Q2 		$22.6M Buy
1,415,346
+501,625
+55% +$8.94M 0.01% 1265
2025
Q1 		$17.8M Buy
913,721
+460,021
+101% +$9.68M 0.01% 1396
2024
Q4 		$10M Buy
+453,700
New +$8.73M ﹤0.01% 1843

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Raymond James Financial's CLBT Position: Q2 2026 in Review

Raymond James Financial increased its Cellebrite (CLBT) stake by 15% in Q2 2026, buying an estimated $2.78M and bringing the position to 1,600,460 shares worth $23.4M. The position accounts for 0.01% of the portfolio, ranked #1446.

Raymond James Financial first reported a position in CLBT in Q4 2024 and has held it in 7 quarters since. The position peaked at $27.7M in Q3 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Raymond James Financial held 1,600,460 shares of Cellebrite worth $23.4M as of Q2 2026.
  • Raymond James Financial bought 210,571 Cellebrite shares in Q2 2026, an estimated $2.78M.
  • Cellebrite made up 0.01% of Raymond James Financial's portfolio in Q2 2026, its #1446 holding.
  • Raymond James Financial first reported a position in Cellebrite in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Cellebrite position peaked at $27.7M in Q3 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.